Call for a Global Vaccine Plan to Combat Current and Future Pandemics: One for ALL and ALL for One
Salim Surani1, *, Pahnwat T. Taweesedt2, Sara Surani3, Iqbal Ratnani4, Joseph Varon5
Identifiers and Pagination:Year: 2022
E-location ID: e187430642202040
Publisher ID: e187430642202040
Article History:Received Date: 21/9/2021
Revision Received Date: 22/11/2021
Acceptance Date: 29/12/2021
Electronic publication date: 15/03/2022
Collection year: 2022
open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
The emergence of SARS-CoV-2 in late December 2019 has taken the world by storm. In March 2020, the World Health Organization (WHO) named this virus COVID-19. To date, it has infected approximately 186 million people worldwide and is attributed as the cause of death of more than 5 million people (and this number is only increasing.) The global effort to develop vaccines and therapeutics occurred at the fastest pace yet, with several vaccines' approval under emergency authorization use. There are also several post-marketing side effects, including myocarditis, cerebral venous embolism, and Guillain Barre Syndrome. Global vaccine disparity complicates the control of pandemic challenges. Several highly infectious variants have emerged, and more variants are feared to emerge if global vaccination plans are not developed soon.